Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4794509
Max Phase: Preclinical
Molecular Formula: C16H12N2O2S2
Molecular Weight: 328.42
Molecule Type: Unknown
Associated Items:
ID: ALA4794509
Max Phase: Preclinical
Molecular Formula: C16H12N2O2S2
Molecular Weight: 328.42
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=Cc1ccc(-c2cc3ncnc(SCC(=O)O)c3s2)cc1
Standard InChI: InChI=1S/C16H12N2O2S2/c1-2-10-3-5-11(6-4-10)13-7-12-15(22-13)16(18-9-17-12)21-8-14(19)20/h2-7,9H,1,8H2,(H,19,20)
Standard InChI Key: VMPKPSHIYIYJEW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 328.42 | Molecular Weight (Monoisotopic): 328.0340 | AlogP: 4.18 | #Rotatable Bonds: 5 |
Polar Surface Area: 63.08 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 4.28 | CX Basic pKa: 2.01 | CX LogP: 4.08 | CX LogD: 1.10 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.56 | Np Likeness Score: -1.16 |
1. Picado A,Chaikuad A,Wells CI,Shrestha S,Zuercher WJ,Pickett JE,Kwarcinski FE,Sinha P,de Silva CS,Zutshi R,Liu S,Kannan N,Knapp S,Drewry DH,Willson TM. (2020) A Chemical Probe for Dark Kinase STK17B Derives Its Potency and High Selectivity through a Unique P-Loop Conformation., 63 (23.0): [PMID:33215924] [10.1021/acs.jmedchem.0c01174] |
Source(1):